These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24331018)

  • 1. The China GAVI Project.
    Berkley S
    Vaccine; 2013 Dec; 31 Suppl 9():J3-4. PubMed ID: 24331018
    [No Abstract]   [Full Text] [Related]  

  • 2. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
    Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
    Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origins, design and implementation of the China GAVI project.
    Liang X; Cui F; Hadler S; Wang X; Luo H; Chen Y; Kane M; Shapiro C; Yang W; Wang Y
    Vaccine; 2013 Dec; 31 Suppl 9():J8-14. PubMed ID: 24331025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project.
    Yang W; Liang X; Cui F; Li L; Hadler SC; Hutin YJ; Kane M; Wang Y
    Vaccine; 2013 Dec; 31 Suppl 9():J73-8. PubMed ID: 24331024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the GAVI Alliance in improving childhood hepatitis B vaccination in China: successes, lessons learned, and future global challenges.
    Averhoff F; Kolwaite A; Ward JW
    Vaccine; 2013 Dec; 31 Suppl 9():J5-7. PubMed ID: 23623862
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation.
    Cui F; Luo H; Wang F; Zheng H; Gong X; Chen Y; Wu Z; Miao N; Kane M; Hennessey K; Hadler SC; Hutin YJ; Liang X; Yang W
    Vaccine; 2013 Dec; 31 Suppl 9():J36-42. PubMed ID: 24331019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant progress made in hepatitis B control in China.
    Zhu C
    Vaccine; 2013 Dec; 31 Suppl 9():J1. PubMed ID: 24331014
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of hepatitis B vaccine in China and in the China GAVI Project.
    Hadler SC; Fuqiang C; Averhoff F; Taylor T; Fuzhen W; Li L; Xiaofeng L; Weizhong Y
    Vaccine; 2013 Dec; 31 Suppl 9():J66-72. PubMed ID: 24331023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foreword. Hepatitis B and the impact of immunization in China and the WHO Western Pacific Region.
    Yu W
    Vaccine; 2013 Dec; 31 Suppl 9():J2. PubMed ID: 24331016
    [No Abstract]   [Full Text] [Related]  

  • 10. The next step in controlling HBV in China.
    Xu Y; Liu H; Wang Y; Hao R; Li Z; Song H
    BMJ; 2013 Jul; 347():f4503. PubMed ID: 23861426
    [No Abstract]   [Full Text] [Related]  

  • 11. Priorities and challenges for hepatitis B control in the Philippines and the importance of a vaccine dose at birth.
    Ruff TA; Bravo L; Gatchalian SR; Bock HL
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):972-90. PubMed ID: 19842381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and prevention of hepatitis B virus infection in China.
    Lu FM; Li T; Liu S; Zhuang H
    J Viral Hepat; 2010 Mar; 17 Suppl 1():4-9. PubMed ID: 20586928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing hepatitis B though universal vaccination: reduction of inequalities through the GAVI China project.
    Cui F; Liang X; Gong X; Chen Y; Wang F; Zheng H; Wu Z; Miao N; Hadler SC; Hutin YJ; Luo H; Yang W
    Vaccine; 2013 Dec; 31 Suppl 9():J29-35. PubMed ID: 24331017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global status of HB immunization, 1998.
    Kane MA
    Acta Gastroenterol Belg; 1998; 61(2):237. PubMed ID: 9658619
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese rural communities.
    Zhang Y; Ma JC; Qi SX; Wang F; Zhao C; Bi SL
    Vaccine; 2011 May; 29(22):3905-8. PubMed ID: 21457729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving ultimate control of hepatitis B infection in China: progress and challenges.
    Jia JD; Yao GB
    J Viral Hepat; 2010 Mar; 17 Suppl 1():2-3. PubMed ID: 20586927
    [No Abstract]   [Full Text] [Related]  

  • 17. Implementing a national policy for hepatitis B birth dose vaccination in Philippines: lessons for improved delivery.
    Sobel HL; Mantaring JB; Cuevas F; Ducusin JV; Thorley M; Hennessey KA; Nyunt-U S
    Vaccine; 2011 Jan; 29(5):941-5. PubMed ID: 21115051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denmark decides not to introduce hepatitis B into the childhood vaccination programme.
    Cowan SA
    Euro Surveill; 2005 Nov; 10(11):E051103.3. PubMed ID: 16794274
    [No Abstract]   [Full Text] [Related]  

  • 19. Debate revived on hepatitis B vaccine value.
    Marwick C; Mitka M
    JAMA; 1999 Jul; 282(1):15-7. PubMed ID: 10404894
    [No Abstract]   [Full Text] [Related]  

  • 20. [Epidemiological effect of hepatitis B immunization among newborn babies in Beijing].
    Gong XH; Liu LR; Jia L; Li YH; Xing YL; Wang QY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):201-2. PubMed ID: 12716513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.